Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    8831595 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin
Condition: Cirrhosis
Interventions: Drug: Terlipressin;   Drug: Placebo
2 Unknown  Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction
Condition: Tense Ascites in Cirrhosis
Interventions: Drug: albumin 4 gr/L ascites removed;   Drug: albumin 8 gr/L ascites removed

Indicates status has not been verified in more than two years